For adults with fatty liver disease, eating all meals within an 8-hour window each day lowers blood triglyceride levels more than spreading the same meals throughout the day, even when total food intake is unchanged.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether 16:8 TRE consistently reduces triglycerides in MASLD across populations, accounting for baseline lipid levels, adherence, and dietary composition.
A systematic review and meta-analysis of all RCTs comparing 16:8 TRE versus isocaloric standard eating in adults with MASLD, including at least 12 studies with 1,000+ participants total, measuring fasting triglycerides as primary outcome over 8–24 weeks.
Whether 16:8 TRE causes sustained reduction in triglycerides over 24 weeks in MASLD patients with hypertriglyceridemia (≥150 mg/dL), independent of weight loss.
A multicenter, double-blind RCT of 200 adults with MASLD and baseline triglycerides ≥150 mg/dL, randomized to 16:8 TRE or matched-calorie standard eating for 24 weeks, with fasting triglycerides measured at baseline, 12, and 24 weeks, and weight change as a covariate.
Whether adults with MASLD who adopt 16:8 TRE over 5 years have lower incidence of cardiovascular events compared to those who follow standard eating.
A prospective cohort study following 700 adults with MASLD and hypertriglyceridemia for 5 years, stratified by adherence to 16:8 TRE (≥70% days), measuring annual triglyceride trends and incident cardiovascular events, adjusting for BMI, diabetes, and statin use.
Whether individuals with MASLD who experienced a cardiovascular event over 3 years were less likely to have practiced 16:8 TRE compared to those who remained event-free.
A case-control study comparing 140 MASLD patients who had a cardiovascular event within 3 years to 140 matched controls who remained event-free, assessing prior adherence to 16:8 TRE via structured dietary recall and wearable data.
Whether adults with MASLD currently practicing 16:8 TRE have lower triglyceride levels than those not practicing it, in a representative population.
A cross-sectional survey of 1,300 adults with MASLD, measuring current TRE adherence and fasting triglycerides via standardized lab measurement, adjusting for age, sex, BMI, and statin use.